Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Terray Therapeutics | 2025 | Debt Financing | $25.0M | Monrovia |
| Zoo | 2025 | Undisclosed | Undisclosed | Inglewood |
| Anagram | 2025 | Series A | $10.0M | New York |
| Eclypsium | 2025 | Series C | $45.0M | Portland |
| HockeyStack | 2025 | Series A | $26.0M | Middletown |
| Bolt.new | 2025 | Series B | $105.5M | San Francisco |
| Archway | 2024 | Undisclosed | $7.0M | Redmond |
| Aizen Therapeutic | 2024 | Seed | $13.0M | San Diego |
| Anomaly | 2024 | Series Unknown | $13.1M | New York |
| Archon Biosciences | 2024 | Seed | $20.0M | Washington |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 101 | Terray Therapeutics | Debt Financing | $25.0M | Monrovia, United States |
| 102 | Zoo | Undisclosed | Undisclosed | Inglewood, United States |
| 103 | Anagram | Series A | $10.0M | New York, United States |
| 104 | Eclypsium | Series C | $45.0M | Portland, United States |
| 105 | HockeyStack | Series A | $26.0M | Middletown, United States |
| 106 | Bolt.new | Series B | $105.5M | San Francisco, United States |
| 107 | Archway | Undisclosed | $7.0M | Redmond, United States |
| 108 | Aizen Therapeutic | Seed | $13.0M | San Diego, United States |
| 109 | Anomaly | Series Unknown | $13.1M | New York, United States |
| 110 | Archon Biosciences | Seed | $20.0M | Washington, United States |
Terray Therapeutics is a biotechnology company that transforms small molecule drug discovery.
Zoo creates infrastructure for hardware design.
Anagram offers a platform for human-driven security.
Eclypsium offers a platform for supply chain security for IT infrastructure.
HockeyStack is the command center for B2B revenue teams that provides modern attribution, unified buyer journeys, and account insights.
Bolt.new is an AI development platform that offers building, running, editing, and deploying services for full-stack applications.
Archway Software offers a single entry point to seamlessly connect any banking platform to outside financial software suppliers.
Aizen is an AI-driven biotech company developing Mirror Peptides, a new class of biologic medicines.
Anomaly is a fintech company that offers a precision payments platform for healthcare services.
Archon Biosciences is a biotechnology firm that promotes next-generation antibody treatments through AI and computational protein design.
Read AI is a productivity AI company that enhances workflows with meeting analytics, scheduling, and summaries across messages and email.
Storia AI creating a creative assistant to facilitate quick and enjoyable video production.
Route is a software company that develops application to track and protect logistics and freight services.
Tektonic AI provides GenAI agents for business operations meant to automate complicated and dynamic tasks.
Vilya is a biotechnology company developing a novel class of drugs that precisely target the biology of disease.
TerraClear is an agricultural technology company focused on improving farmers' productivity through end to end automation.
Unstructured is an enterprise ETL tool that automatically transforms complex, unstructured data into clean, structured data for GenAI.
Codified helps enterprises manage data access for Generative AI apps, ensuring compliance and reducing security risks.
Magnify is a post-sales orchestration platform that uses AI and machine learning to optimize and automate the customer lifecycle.
Finpilot uses artificial intelligence to explore publicly available corporate files and respond to research requests in natural language.
Strike Graph is a compliance SAAS solution simplifying cyber security certifications.
Rhythms offers generative AI, the prevalence of hybrid workplaces, the imperative to do more with less are reshaping organizations function.
Tangibly is a platform for businesses to manage their intellectual property by securing their trade secrets in legally enforceable form.
NoxuData is integrating large language models with traditional enterprise data.
Madrona has invested in 202 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Madrona's top investment sectors include Artificial Intelligence (AI), Software, Information Technology, Biotechnology, SaaS. The firm invests across 51 different industry categories.
Among tracked funding rounds, Bolt.new received $105.5M in a Series B round. Madrona's total known invested capital is $5.3B.
Madrona's average investment size is $39.0M across its portfolio of 202 companies.
Recent Madrona portfolio additions include Terray Therapeutics, Zoo, Anagram, Eclypsium, HockeyStack. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors